logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

投资基因编辑疗法公司CRISPR Therapeutics (CRSP) 的核心理由

Two Engines Drive the Future, Market Continues Betting on Lilly

Dec 15, 2025

Life Science

2x Valuation Gap: BIO vs. CRL — Who’s Wrong?

Immunome Soars 15% as Phase 3 Trial of Desmoid Tumor Drug Achieves Overwhelming Success

Dec 15, 2025

Life Science

2025年值得关注的三只金融科技股票

Which Healthcare Stocks Will Stand Out in 2026?

Dec 12, 2025

Life Science

新法案提案提振,诺和诺德逆市上扬

Boosted by New Legislative Proposal, Novo Nordisk Rises Against Market Trend

Dec 11, 2025

Life Science

押注未来:瞄准2026年高增长潜力的两家生物科技公司

Stock Price Hits New High! Why Has Gene Therapy Pioneer BridgeBio Become a Market Focus?

Dec 11, 2025

Life Science

Intel and Sandisk Rally Sharply, Fueling Debate Over Divergent Downside Risks

Price Target Soars 270%: Why Analysts Are So Bullish on This Biotech Stock

Dec 10, 2025

Life Science

诺华借力AI生物科技,开拓过敏药物新前沿

Novartis Leverages AI Biotechnology to Explore New Frontiers in Allergy Drugs

Dec 9, 2025

Life Science

减肥候选药获积极数据,Structure Therapeutics股价飙升

Structure Therapeutics’ Stock Price Surged After Positive Data From a Weight-loss Drug Candidate

Dec 9, 2025

Life Science

Wave Life Sciences Soars 147% on Breakthrough "Targeted Fat Loss" Drug Data

Wave Life Sciences Soars 147% on Breakthrough “Targeted Fat Loss” Drug Data

Dec 8, 2025

Life Science

谁将主宰下一代减肥药?礼来、Viking激战正酣

How Are the Three Pharmaceutical Giants Navigating Industry Changes?

Dec 5, 2025

Life Science

这两家医疗保健企业为何值得长期持有?

Why Are These Two Healthcare Companies Worth Holding for the Long Term?

Dec 4, 2025

Life Science

大型基金4470万万美元建仓数字医疗新星

Large Fund Establishes a $44.7 Million Position in Digital Health Rising Star

Dec 3, 2025

Life Science

挑战还是机遇?联合健康集团迎来价值重塑的关键时刻

Challenge or Opportunity? UnitedHealth Group Faces a Critical Moment of Value Reassessment

Dec 3, 2025

Life Science

A “Price-for-Tariffs” Deal: Could the UK’s Pact with the US Become Europe’s Template?

A “Price-for-Tariffs” Deal: Could the UK’s Pact with the US Become Europe’s Template?

Dec 2, 2025

Life Science

年末压轴布局:两大高增长赛道龙头蓄势待发

Year-End Finale Layout: Leading Players in Two High-Growth Sectors Poised for Action 

Dec 1, 2025

Life Science, Technology

押注未来:瞄准2026年高增长潜力的两家生物科技公司

Betting on the Future: Two Biotech Companies with High Growth Potential Targeted for 2026

Dec 1, 2025

Life Science

Biotech Stocks Surge 61% as CRISPR, Vertex Emerge as Top Picks

Regeneron Soars 5%: Can an Old Blockbuster Drug’s New Chapter Restore Investor Confidence?

Dec 1, 2025

Life Science

5 Pharma Stocks Offering 3%+ Dividend Yields for Uncertain Times

Positioning for 2026: A Look at CFRA’s Top Healthcare Stock Picks

Nov 30, 2025

Life Science

  • ‹‹ Previous
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada